The newly identified intercellular miR-221-3p-VASH1 axis illustrated a critical molecular mechanism of CSCC progression and provided a novel diagnostic and therapeutic target for CSCC patients with LN metastasis. The gene discussed is VASH1; the disease is lobular neoplasia.